A recent National Academies of Sciences, Engineering, and Medicine report details several adverse impacts from poor diversity in clinical trials. These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and excluded populations, and hindering innovation. Read the Full Article.
Home / Community / Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
Recent Posts
- Researchers Assess the Gender and Wealth Gap Within School Climate.
- Ozempic in a Pill? It’s Closer Than You Think.
- NJIT Students Develop Mental Health Side-Effect Tracker Recognized at Pfizer Hackathon.
- Older Adults With HIV May Be Facing Unequal Burden in the Opioid Crisis.
- Rutgers Medical Students Learn Importance of Humanity, Creativity and Connection in Patient-Centered Medicine.
Categories
- Community (2,366)
- Covid (992)
- CTO Events (6)
- News (3,003)
- Pilots (21)